Cite
APA Citation
Fleseriu, M., Newell-Price, J., Pivonello, R., Shimatsu, A., Auchus, R. J., Scaroni, C., Belaya, Z., Feelders, R. A., Vila, G., Houde, G., Walia, R., Izquierdo, M., Roughton, M., Pedroncelli, A. M., & Biller, B. M. K. (2022). long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension. European journal of endocrinology, 187(4), 531–541. http://access.bl.uk/ark:/81055/vdc_100179864851.0x000040